| Title | Date | PubMed ID |
|---|
| Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice. | 2011 Feb 2 | 21311597 |
| Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival. | 2011 | 21655347 |
| The effect of C-terminal domain deletion on the catalytic activity of Leishmania donovani surface proteinase GP63: Role of Ser446 in proteolysis. | 2010 Dec | 20678540 |
| Genome survey sequence analysis and identification of homologs of major surface protease (gp63) genes in Trypanosoma rangeli. | 2010 Nov | 20420528 |
| Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. | 2010 Oct 14 | 20976196 |
| Leishmanolysin-like molecules in Herpetomonas samuelpessoai mediate hydrolysis of protein substrates and interaction with insect. | 2010 Oct | 20359946 |
| Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. | 2009 Sep 29 | 19797268 |
| The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63). | 2009 Apr | 19211022 |
| The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. | 2009 Mar 13 | 19064994 |
| Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. | 2008 Aug | 18713141 |